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SUMMARY 
It has been shown that the acetamido methyl protons of 
N-acetyl-D-glucosamine undergo a chemical shift to higher 
fields in their proton magnetic resonance spectrum when the 
inhibitor is bound to lysozyme. The observed chemical 
shift in the presence of the enzyme is different for the CP 
and /3-anomeric forms of Z-acetamido-Z-deoxy-D-gluco- 
pyranose indicating either a difference in the afhnity of the 
anomeric forms for lysozyme or different magnetic environ- 
ments for the methyl protons in their enzyme-bound state. 
That the CX- and @-anomeric forms of GlcAc bind to lysozyme 
in a competitive fashion was indicated by observing the 
proton magnetic resonance spectra in the presence of Z- 
acetamido-d&!-deoxy-cr-n-glucopyranose. The methyl gly- 
cosides, methyl-cr-GlcAc and methyl+GlcAc, were also 
shown to bind competitively with both anomers of GlcAc. 
Quantitative analysis of the chemical shift data observed for 
the association of GlcAc with lysozyme was complicated by 
the mutarotation of GlcAc between its CX- and /3-anomeric 
forms. However, in the case of the methyl glucosides, 
where the conformation of each anomer is frozen, it was 
possible to analyze the chemical shift data in a straight- 
forward manner, and the dissociation constant as well as the 
chemical shift of the acetamido methyl protons of the enzyme- 
inhibitor complex was determined for both anomers. The 
results indicate that the two anomers of methyl-GlcAc bind 
to lysozyme with slightly different afRnities but that the 
acetamido methyl groups of both anomers experience identi- 
cal magnetic environments in the enzyme-inhibitor complex. 
Many physical tools have been used to investigate enzyme- 
substrate and enzyme-inhibitor interactions in solution. In 
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general, most of these studies do not yield detailed information 
regarding the nature of such interactions. Nuclear magnetic 
resonance spectroscopy, however, by virtue of its extreme sen- 
sitivity to minute structural and conformational changes within 
molecules and to environmental effects, promises to be a poten- 
tially important spectroscopic method for the study of such 
processes. 
Most of the results reported so far (1, 2) have been concerned 
with linewidth changes of the nuclear resonances of the small 
molecule upon association with the macromolecule. This 
method has been used to study the binding of penicillin G to 
bovine serum albumin (2) and the association of ethanol and 
DPN to an alcohol dehydrogenase (3, 4). Selective broadening 
of some of the proton resonances of the small molecules has been 
observed and has been interpreted as indicating intimate contact 
between such protons (or neighboring groups) and the macro- 
molecule. 
In general, one also expects chemical shift changes for some 
nuclei of the inhibitor or substrate molecule when it is bound to 
the enzyme. If  the small molecule exchanges rapidly between 
the free and complexed environments, the observed spectral 
positions of the affected resonances will be shifted from their 
corresponding positions for the unassociated molecule by amounts 
which depend upon the chemical shifts of these nuclei in the 
complex as well as on the fraction of the inhibitor or substrate 
molecules in the complexed state. One might argue that the 
chemical shift changes are more stereospecific than the linewidth 
changes in these studies, and hence provide a more sensitive 
probe of the active site and the nature of the enzyme-substrate 
or enzyme-inhibitor interactions. However, the chemical shift 
changes are in general considerably smaller than the accompany- 
ing broadening of the resonances and are therefore more dif- 
ficult to measure. 
Since the work described in this communication was started,’ a 
preliminary account of a study of the association of 2-aceta- 
mido-2-deoxy-n-glucopyranide and related compounds with 
IA preliminary account of the work described here was pre- 
sented at the Gordon Research Conference on Proteins, New 
Hampton School, New Hampshire, June 27, 1966. Preliminary 
reports of similar proton magnetic resonance studies on lyso- 
zyme (5) and chymotrypsin (6) association with inhibitors have 
appeared. 
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4176 PMR study of Lysoxyme-Inhibitor Interactions Vol. 243, No. 16 
FIG. 1. A, proton magnetic resonance spectrum at 60 MHz of 
the acetamido methyl protons of GlcAc (5 X lo-* M) in 0.1 M 
citrate, pH 5.5. Acetone (0.5%) is used as an internal standard 
and its resonance appears to lowest field in spectrum. A sweep 
width of 50 cps was used. B, proton magnetic resonance spectrum 
at 60 MHz of a similar solution of GlcAc as shown in A with added 
lysozyme (3 X lWs M). 
lysozyme as detected by PMR2 methods has appeared (5). In 
addition to line-broadening effects caused by binding, it was 
observed that the resonance of the acetamido methyl groups of 
various GlcAc derivatives were shifted to higher field in the 
presence of lysozyme. This effect was observed for a-GlcAc, 
fl-GlcAc, methyl-a-GlcAc, methyl-&GlcAc, and N-acetyl-n- 
galactosamine. 
In this communication, we present the results of an investiga- 
tion of the chemical shift changes occurring in the association of 
lysozyme with some speciiic inhibitors. The emphasis of this 
work is on the quantitation of such chemical shifts and the in- 
terpretation of the results obtained to infer information regard- 
ing the microscopic environment experienced by the inhibitor 
when bound to the enzyme. 
MATERIALS AND METHODS 
N-Acetyl-n-glucosamine (m.p. 203-205”) was purchased from 
Calbiochem. N-Acetyl-de-D-glucosamine was obtained by 
acetylation of D-glucosamine-HCl (Calbiochem) with acetic 
anhydride-& (Volk Radiochemical Company (Chicago)) accord- 
ing to published procedures (7). Recrystallization of the 
resulting N-acetyl(d&cr-D-glucopyranose was effected from 
aqueous-alcohol mixtures (m.p. 203-205”). Methyl-a-acetamido- 
2-deoxy-cr-n-glucopyranoside (m.p. 188”) was synthesized &s 
* The abbreviations used are: PMR, proton magnetic resonance; 
methyl-cr-GlcAc, methyl-2-acetamido-2-deoxy-wn-glucopyrano- 
side; methyl-&GlcAc, methylS-acetamido-2-deoxy-&n-glucopy- 
ranoside; GlcAc, 2-acetamido-2-deoxy-n-glucopyranide. 
previously reported (8) and purified by chromatography on a 
charcoal-Celite column. Methyl-2-acetamido-2-deoxy-P-D-glu- 
copyranoside (m.p. 204-205’) was synthesized (9) from D-gh- 
cosamine. Lysozyme (Lot 668-8590) was obtained from Sigma. 
The BO-MHz PMR spectra were recorded on a Varian A-60A 
spectrometer at a probe temperature of 40”. A Varian HA-100 
spectrometer, operating in frequency sweep mode, was used for 
the lOO-MHz PMR spectra, which were measured at 30”. The 
water resonance was used as a lock signal for the studies in Hz0 
while a capillary of TMS was used in the studies conducted in 
DzO. 
The chemical shifts for the loo-MHz spectra were obtained by 
counting the frequency difference between the manual oscillator 
and the sweep oscillator on the HA-100 spectrometer with a 
Hewlett Packard model 5212A counter. All chemical shifts were 
measured relative to an internal standard of acetone (0.5%). 
In each case, except those for mutarotational studies, the chem- 
ical shifts were measured at least three times with a standard 
deviation of 0.04 cps or less. Data were analyzed by methods of 
least squares. 
Enzyme concentrations of samples used for the PMR measure- 
ments were determined from ultraviolet absorbance at 280 mp of 
a 25-~1 aliquot, after dilution to 5 ml with water, with the use of 
the known extinction coefficient (9) for lysozyme. 
RESULTS 
The PMR spectrum at 60 MHz of N-acetyl-D-glucosamine 
exhibits a resonance at 7 8.09, which can be unambiguously as- 
signed to the methyl group protons of the acetamido side chain 
(10). Because it is the most intense resonance in the spectrum 
and is unsplit, it is best suited for our present study. Fig. 1A 
shows this resonance at 60 MHz with an acetone internal stand- 
ard included in the sample. The addition of lysozyme (3 x lWa 
M final concentration) to this same sample of GlcAc (5 X 1W2 M) 
resulted in the spectrum shown in Fig. 1B. From the known 
binding constant (ll), it was determined that approximately 5% 
of the total GlcAc present was bound to the enzyme under these 
conditions. Two resonances instead of one were observed for 
these acetamido methyl protons in the presence of the enzyme. 
Both of these resonances were broadened, and both appeared at 
higher fields from the position of the original GlcAc methyl 
resonance (0.9 Hz and 3.3 Hz, respectively). 
As proof that the effects observed in the PMR spectra of 
GlcAc in the presence of lysozyme were due to association be- 
tween the inhibitor and the enzyme rather than to bulk sus- 
ceptibility effects in the relatively concentrated protein solution, 
the PMR spectra of GlcAc in similarly concentrated solutions of 
ribonuclease A were also recorded. Such a spectrum is dis- 
played in Fig. 2. In addition to the absence of the additional 
resonance observed in the presence of lysozyme, it was shown 
that the addition of ribonuclease to a GlcAc solution did not 
result in any chemical shift of the acetamido methyl resonance 
from its position in free GlcAc. Neither was the methyl reso- 
nance noticeably broadened. It was further substantiated that 
the concentration of GlcAc itself did not affect the chemical 
shift of its acetamido methyl protons. No concentration shifts 
were observed over the concentration range 10m2 M to 10-l M. 
To ascertain that the two observed methyl resonances of GlcAc 
in the presence of Iysozyme correspond to the acetamido methyl 
groups of the (Y- and @-anomeric forms of the inhibitor a freshly 
dissolved sample of a-GlcAc was used. Fig. 3 summarizes the 
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PMR spectra of the GlcAc methyl protons in the presence of the 
enzyme obtained at various intervals during the mutarotation 
of GlcAc from the a-anomeric form to the equilibrium mixture 
of a and fi anomers. Lysozyme was also added to a fresh sample 
of b-GlcAc prepared by acetylation of P-n-glucosamine (12). 
The spectrum for this solution showed at early times only the 
methyl resonance which we have attributed to the /3 anomer in 
Fig. 3, with subsequent development of the resonance due to the 
Q! anomer. 
These observations are in agreement with those previously 
observed (5) for GlcAc in the presence of lysozyme, and they are 
also in accord with the results obtained from x-ray analysis 
studies (13) of lysozyme-GlcAc complexes in the crystalline state 
which have shown that both anomers of the sugar bind to the 
enzyme. Earlier studies in this laboratory (11) with ultraviolet 
spectroscopic methods allowed estimation of the dissociation 
constant for the lysozyme-GlcAc complex (K, = 4 to 6 x RI+ 
M). This value obviously represents the binding of both forms 
of ClcAc and is a complex constant. 
It is evident from our present observations that the chemical 
exchange of both anomeric forms of the inhibitor GlcAc between 
the free and enzyme bound species is rapid. It is also evident 
that both anomers of GlcAc, when bound to lysozyme have their 
acetamido methyl groups in environments which lead to increased 
magnetic shielding of these protons, since the resonances ob- 
served for both anomers are shifted upfield from their positions 
in the absence of the enzyme. The fact that we observe separate 
resonances for the a! and j3 anomers in the presence of lysozyme 
indicates that the two anomeric forms bind to the enzyme either 
with different affinities, or in a manner such that their acetamido 
side chains do not occupy the same position on the enzyme or 
both. These conclusions are possible, whether or not the two 
anomers bind to different sites or compete for the same sites on 
the enzyme surface. In addition, the rate of interconversion 
of GlcAc between its (Y and /3 anomers must be slow. 
To decide whether the (Y- and S-anomeric forms of GlcAc 
GlcAc + RNase A 
I * 
FIG. 2. The acetamido methyl PMR spectrum at 60 MHz of 
GlcAc (5 X 10-1 M) in the absence and in the presence of ribo- 
nuclease A (3 X 10-a M), in 0.1 M citrate, pH 5.5. Acetone (0.5%) 
was used as an internal reference, and appears to lower field. 
_” 
MOmin& L I* I 9.5 min 
FIG. 3. Time study of the PMR spectrum of ~GlcAc (5 X 10-l 
an) after addition to lysoayme (3 X 10-* M) in 0.1 M citrate in DzOt 
pD 5.9. A solution of acetone (0.5%) was used as an internal 
standard, and its resonance appears to lower field of the GlcAc 
resonances. 
compete for the same sites on the enzyme surface, a sample of 
crystalline N-acetyl(&)-cr-n-glucopyranose (m.p. 203-205”) was 
added to an equilibrated mixture of GlcAc and lysozyme and the 
PMR spectrum was recorded at 60 MHz within 2 min after 
mixing. As seen in Fig. 4, the added a-(&) anomer (although 
not observable) decreased the observed chemical shifts (and 
therefore the percentage bound) of both (Y- and /3-GlcAc. Table 
I shows the quantitative effects observed. As can be seen from 
Table I, both anomers were approximately equally affected by 
the added a-(&) anomer. The conclusion from this experi- 
ment is that cr-GlcAc and /3-GlcAc do compete for the same 
sites on the enzyme. 
A quantitative analysis of the chemical shift data obtained for 
the GlcAc-lysozyme system is complicated by the mutarotation 
equilibrium between the (Y and fi anomers of the inhibitor, since 
the enzyme would shift this equilibrium if the two anomeric 
forms bind to the enzyme with different affinities. For facilita- 
tion of quantitative treatment of the experimental data, identical 
binding studies were therefore repeated with the methyl glyco- 
sides of GlcAc, where the conformation of each anomer is frozen. 
Table II summarizes the results obtained at 100 MHz for the 
association of lysozyme with methyl-Ar-acetyl-/3-n-glucopyrano- 
side and separately with methyl-2\r-acetyl-a-n-glucopyranoside. 
That methyl-cu-GlcAc and methyl-&GlcAc compete for the 
same sites on the enzyme surface was shown by adding N- 
acetyl(&)-ar-n-glucopyranose to a solution of lysozyme contain- 
ing either methyl-a-GlcAc or methyl+GlcAc, and showing 
that the added deuterated compound reduced the amount of 
bound methyl-ar-Glchc or methyl-p-GlcAc. Table III gives 
the quantitative data obtained. Methyl-a-GlcAc and methyl- 
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GlcAc where 6 is the observed chemical shift of the average methyl 
(A) A 
resonance referred to that of the unbound inhibitor, A is the 
chemical shift difference for the methyl resonance between the 
bound and unbound species, K, is the enzyme-inhibitor dis- 
sociation constant, and Eo and SO denote the total concentrations 
of the enzyme and inhibitor, respectively. In the limit where 
6/A < 1, a condition which is fairly well satisfied in our experi- 
0 -&AC ments, Expression 2 simplifies and may be rearranged to give 
(B) So = Eo ; - K, - E,, (3) 
Thus, if the enzyme-inhibitor binding is studied by varying the 
inhibitor concentration at a fixed concentration of enzyme, a 
plot of SO with respect to the observed l/6 limits should yield a 
straight line with slope EoA and intercept equal to - (K. + Eo), 
provided the above conditions are met. 
The chemical shift data obtained for methyl-a- and methyl- 
/?-GlcAc are plotted in this manner in Fig. 5. In these experi- 
I I 
TABLE II 
Chemical shift data for acetamido methyl protons of methyl-a-GlcAc 
FIG. 4. Competitive binding to lysozyme of ~GlcAc and /3- 
and methyl-&GlcAc association with lysozyme (3.0 X ~O+M) 
GlcAc. The resonance caused bv acetone protons is shown at Measurements were made at 100 MHz, in 0.1 M citrate buffer, 
left. Other resonances shown are (A) the acetamido methyl 
proton resonance of free GlcAc; (B) GlcAc (at mutarotation 
equilibrium, 1.6 X IO-2 M) in the presence of Iysozyme; (C) same 
as in B but with added ol-GlcAc(d3) (6.7 X 10-z M). In this case, 
the spectrum was recorded immediately after addition of the 
a-deuterio anomer. 
pH 5.5, at 31”. 
so x 10’ 
- 
- 
l/8 6 
Hz 
1.30 0.769 
1.69 0.592 
1.82 0.549 
1.95 0.513 
2.39 0.418 
1.45 0.690 
1.71 0.585 
1.95 0.513 
2.20 0.454 
2.43 0.412 
3.13 0.320 
Methyl-or-GlcAc 
7.15 
4.29 
3.57 
2.86 
1.43 
Methyl-o-GlcAc 
7.21 
5.77 
4.33 
TABLE I 
Chemical shift data for acetamido methyl protons of ~GlcAc and 
/+GlcAc association with lysozyme in absence and 
presence of a-GlcAc(da) 
Measurements were made at 60 MHz in 0.1 M citrate buffer, 
pH 5.5, at 40”. 
1 Concentration / -. . . .I 1 
Inhibitor 
Inhibitor 
a-, ,v-GlcAc. 0.:5 
cr-GlcAc 0.008 
b-GlcAc . 0.008 
a-GlcAc 0.008 
fl-GlcAc 0.008 
a-GlcAc(da) . 0.067 
0 10.92 
50 14.76 
12.24 
0 
3.84 
1.32 
50 12.54 1.62 
11.50 0.58 
TABLE III 
Chemical shift data for acetamido methyl protons obtained from 
association of methyl-a-GlcAc and methyl+GlcAc with lysozyme 
in absence and presence of cu-GlcAc(da) 
Measurements were made in 0.1 M citrate buffer, pH 5.5, at 
40”, in a Varian A-60A spectrometer. 
Concentration Chemical shift 
relative to 6 
acetone P-GlcAc compete for the same sites on the enzyme occupied by 
a-GlcAc. 
Inhibitor 
The results summarized in Table II can be readily interpreted 
in terms of the following simple equilibrium between the enzyme Methyl-cx-GlcAc 
(E) and the inhibitor (S), Methyl-a-GlcAc 
Methyl-a-GlcAc 
E+S=ES (1) plus 
ET.2 
11.52 0 
13.12 1.60 
12.76 1.24 
11.54 0 
13.84 2.30 
13.18 1.64 
N 
0.05 
0.016 
0.016 
0.019 
0.05 
0.016 
0.016 
0.023 
Under conditions of rapid chemical exchange of the inhibitor 
CCGlcAc (da) 
between its free and enzyme-bound forms, it is readily shown 
Methyl-B-GlcAc 
that 
Methyl-@-GlcAc 
Methyl-&.GlcAc 
plus 
(2) a-GlcAc (da) 
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ments, E. was held fixed at 3.0 X 1O-3 M. It is seen that the 
variation of SO with l/6 is indeed linear for both anomeric 
methyl glycosides over the range of conditions of our enzyme- 
inhibitor binding experiments. From an analysis of these 
plots, we extracted the following dissociation constants and 
chemical shifts for the two enzyme-glycoside complexes: 
K,, = 5.2 f  0.4 X 1O-2 M, A, = 0.55 f  0.02 ppm 
KS8 = 3.3 f  0.5 X IO-% M, As = 0.54 f  0.04 ppm 
Thus, it appears that the two anomeric glycosides bind to lyso- 
zyme with slightly different affinities. However, the results 
indicate that the acetamido methyl groups of both glycosides 
occupy identical magnetic environments when bound to the 
enzyme. 
The results of the above analysis indicate that only one inhibi- 
tor molecule is bound per lysozyme molecule. Thus, if there 
is more than one comparably strong binding site on the enzyme 
surface, it is apparent that the formation of one enzyme-in- 
hibitor complex inhibits binding at the remaining sites. As 
usual, it is not possible to establish the formation of one 1 :l 
enzyme-inhibitor complex rather than several such complexes, 
irrespective of whether binding at one or several sites is responsi- 
ble for the observed spectral changes. The reason for this is 
that the concentration of the various enzyme-inhibitor com- 
plexes are related to one another merely by ratios of their forma- 
tion constants. In our case, where the various 1:l enzyme- 
inhibitor complexes would be in rapid equilibrium with one 
another, the expression for the observed chemical shift can be 
reduced to the same form as Equation 2, with K, and A replaced 
by their appropriate weighted averages, namely 
Here, n denotes the number of binding sites, and the subscript i 
is used to denote the parameters for the ith enzyme-inhibitor 
complex. 
-6r I I I I I I I I 
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 1.0 
L set 
2’ 
FIG. 5. Plots of chemical shift (u) data for the association of 
methvl-ol-GlcAc &Me-GlcAc) and seoaratelv methvl-B-GlcAc 
(b-Me-GlcAc) with lysozyme.’ The or&ate ihowing”Sb X 102 
refers to the concentration of each inhibitor used (1 X KY2 to 
7 X lwa M) in the presence of a constant concentration of the 
enzyme (3 X lOms M). 
DISCUSSION 
The most reasonable explanation of the observed shifts for 
the acetamido methyl protons on the binding of acetamido sugars 
to lysozyme is that these protons become more magnetically 
shielded in the enzyme-bound state because of their environ- 
ment on the enzyme. The most likely causes for this are 
proximity of the methyl group to (a) an aromatic side chain of 
the enzyme (14), or (b) the electric field of an ionizable group 
nearby (15). There is ample evidence (16) that the binding of 
N-acetyl-n-glucosamine and related compounds to lysozyme 
results in a red shift in the spectrum of the enzyme, and this 
observation has been attributed to a tryptophanyl side chain 
becoming less accessible to solvent. In addition, x-ray studies 
(5, 17) of the binding of small sugar molecules such as GlcAc to 
crystalline lysozyme suggest that in the enzyme-inhibitor com- 
plex, the acetamido methyl group is close to the aromatic ring 
of tryptophane residue 108. There is, however, also evidence 
that ionizable groups are present at the binding site of lysozyme 
(18, 19). 
The results of this work indicate that the acetamido methyl 
protons of methyl-cr-GlcAc and methyl-/?-GlcAc experience 
identical magnetic environments in the enzyme-inhibitor com- 
plex. This conclusion is not true in the case of GlcAc where 
both binding constants and chemical shifts for the anomeric 
forms have been shown to be different from each other (20). 
On the other hand, in the methyl glycosides, the glycosidic methyl 
groups of methyl-a-GlcAc and methyl&GlcAc were found to 
experience different magnetic environments when bound to the 
enzyme. In the presence of lysozyme, this methyl resonance 
was shifted to lower fields in methyl&GlcAc, whereas in the 
case of methyl-cr-GlcAc, the glycosidic methyl resonance was 
not noticeably affected. Of the other protons in the GlcAc 
molecule, only those of the 6-hydroxymethyl group were in- 
vestigated in the presence of lysozyme. No observable chemical 
shift of these protons was induced by the enzyme, whereas broad- 
ening of the resonances was observed, as expected. 
We have also been able to showa that other acetamido sugars 
bind to the same site as do the various GlcAc derivatives. Such 
compounds as N-acetyl-n-galactosamine, N-acetyl-n-man- 
nosamine, acetamidocyclohexanol, and acetamidocyclohexane 
all interact with the same site on the enzyme and the methyl 
group of the acetamido side chain undergoes a chemical shift in 
each case. This is consistent with the idea that the acetamido 
side chain is necessary for binding to the enzyme to occur, prob- 
ably through the formation of hydrogen bonds. All the com- 
pounds studied probably form the same hydrogen bonds be- 
tween the enzyme and the acetamido group of the inhibitor, 
but interactions at other “points of contact” between the en- 
zyme and inhibitor molecules may d8er depending on the nature 
of the substituents and their conformation on each pyranose 
ring. 
It would appear from our results that there is at least one 
strong binding site on the enzyme for simple acetamido pyrano- 
sides, such as GlcAc. However, it appears that if there is more 
than one strong binding site on the enzyme surface, the formation 
of one enzyme-inhibitor complex inhibits binding at the re- 
maining sites, so that only I:1 complexes result. This con- 
clusion that only 1 inhibitor molecule is bound strongly per 
lysozyme molecule agrees with previous spectrophotometric 
3 S. M. Parsons and M. Raftery, unpublished observations. 
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studies in this laboratory (12) and elsewhere (19, 21). How- 
ever, these spectrophotometric studies also suggest that there 
are three contiguous binding sites for pyranose rings on the 
enzyme surface, since the binding strength of oligosaccharides 
to lysozyme was found to increase up to the trisaccharide of 
GlcAc (chitotriose) . 
It is felt that these studies show that the use of PMR spec- 
troscopy offers advantages over methods previously used for the 
study of enzyme-inhibitor or enzyme-substrate interactions, 
inasmuch as information regarding the environment experienced 
by the small molecule on association with the macromolecule 
can often be obtained. 
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